Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Dual Impact of Dietary Lipids on Inflammatory Bowel Disease: A Two-Edged Sword

Version 1 : Received: 4 November 2023 / Approved: 6 November 2023 / Online: 7 November 2023 (07:10:30 CET)

How to cite: Kwon, S.J.; Khan, M.S.; Kim, S.G. Dual Impact of Dietary Lipids on Inflammatory Bowel Disease: A Two-Edged Sword. Preprints 2023, 2023110366. https://doi.org/10.20944/preprints202311.0366.v1 Kwon, S.J.; Khan, M.S.; Kim, S.G. Dual Impact of Dietary Lipids on Inflammatory Bowel Disease: A Two-Edged Sword. Preprints 2023, 2023110366. https://doi.org/10.20944/preprints202311.0366.v1

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, is a disease of chronic inflammatory conditions of the intestinal tract due to disturbance of the inflammation and immune system. Symptoms of IBD include abdominal pain, diarrhea, bleeding, reduced weight, and fatigue. In IBD, the immune system attacks the intestinal tract's inner wall, causing chronic inflammation and tissue damage. In particular, IL-6 and IL-17 act on immune cells, including T cells and macrophages, to amplify the immune responses so that tissue damage and morphological changes occur. Of note, excessive calorie intake and obesity also affect the immune system due to inflammation caused by lipotoxicity and changes in lipids supply. Similarly, individuals with IBD have alterations in liver function after sustained high-fat diet feeding. In addition, excess dietary fat intake, along with alterations in primary and secondary bile acids in the colon, can affect the onset and progression of IBD because inflammatory cytokines contribute to insulin resistance; the factors include the release of inflammatory cytokines, oxidative stress, and changes in intestinal microflora, which may also contribute to the disease progression. However, interfering with de novo fatty acid synthase by deleting the enzyme acetyl-CoA-carboxylase 1 in intestinal epithelial cells leads to the deficiency of epithelial crypt structures and tissue regeneration, which seems to be due to Lgr5+ intestinal stem cell function. Thus, conflicting reports exist regarding high-fat diet effects on IBD animal models. This review will focus on the pathological basis of the link between dietary lipids intake and IBD and cover currently available pharmacological approaches.

Keywords

IBD; IECs; Lipid intake; Stem cells; Inflammation

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.